H.-U. Reißig et al.
226.13577; found: 226.13655; elemental analysis calcd (%) for C16H18O
(226.3): C 84.91, H 8.02; found: C 84.71, H 7.97.
26.2, 26.0, 23.1 ppm (8t; CH2); IR (film): n˜ =3435 (OH), 3025–2850 cmꢀ1
+
ꢀ
ꢀ
(=C H, C H); MS (EI, 80 eV): m/z (%): 264 (6) [MꢀH2O] , 207 (100),
128 (70) [C10H8]+.
rac-(3aR,3bR,9bR,11aS)-1,2,3,3b,9b,10,11,11a-Octahydro-3aH-cyclopen-
ta[a]phenanthren-3a-ol (23): According to the general procedure, samari-
um (0.361 g, 2.40 mmol), 1,2-diiodoethane (0.620 g, 2.20 mmol), HMPA
(3.23 g, 18.0 mmol), 21b (0.238 g, 1.00 mmol) and tBuOH (0.148 g,
2.00 mmol) afforded after purification by column chromatography on
silica gel (hexane/ethyl acetate 19:1 to 9:1) 23 (0.193 g, 80%) as a colour-
less solid. M.p.=114–1168C; 1H NMR (CDCl3, 500 MHz): d=7.22–7.09
(m, 3H; Ar), 7.02 (d, J=7.7 Hz, 1H; Ar), 6.52 (d, J=9.5 Hz, 1H; =CH),
6.18 (dd, J=9.5, 5.2 Hz, 1H; =CH), 3.30–3.22 (m, 1H; CH), 2.65 (dd, J=
7.0, 5.2 Hz, 1H; CH), 2.42–2.28 (m, 1H; CH2), 2.04–1.89 (m, 1H; CH2),
1.80–1.70 (m, 1H; CH), 1.65–1.60 (m, 1H; CH2), 1.60–1.55 (m, 2H;
CH2), 1.55–1.20 ppm (m, 5H; CH2); 13C NMR (CDCl3, 126 MHz): d=
137.2, 134.4 (2s; Ar), 129.9, 128.5 (2d; =CH), 127.4, 126.2, 126.0, 124.1
(4d; Ar), 84.1 (s; C-3a), 47.6, 44.2, 36.5 (3d; CH), 33.2, 29.1, 28.0, 24.4,
rac-(3aR,3bR,9bR,11aS)-7-Methoxy-1,2,3,3b,9b,10,11,11a-octahydro-3aH-
cyclopenta[a]phenanthren-3a-ol (28): According to the general proce-
dure, samarium (0.180 g, 1.20 mmol), 1,2-diiodoethane (0.310 g,
1.10 mmol), HMPA (1.61 g, 9.00 mmol), 27 (0.134 g, 0.50 mmol) and
tBuOH (0.074 g, 1.00 mmol) afforded, after purification by column chro-
matography on silica gel (hexane/ethyl acetate 19:1 to 9:1), 28 as a pale-
1
yellow oil (0.038 g, ꢁ28%, purity 80–90%). H NMR (CDCl3, 270 MHz):
d=7.19–7.05 (m, 3H; Ar), 6.44 (dd, Jꢁ9.5, 2.7 Hz, 1H; =CH), 6.20 (brd,
Jꢁ9.5 Hz, 1H; =CH), 3.20–3.00 (m, 1H; CH), 3.75 (s, 3H; OCH3), 2.49
(m, 1H; CH), 2.37–1.01 ppm (m, 12H; CH, CH2, OH).
rac-(4aR,10bR,12aR)-1,3,4,4b,10b,11,12,12a-Octahydro-4aH-spiro[chry-
sene-2,2’-[1,3]dioxolan-4a-ol
3,7,8,8a,9,11,12,12b-octahydro-12aH-spiro
(30)
and
[benzo
rac-(8aR,12aS,12bS)-
[4,5]cyclohepta[1,2,3-
G
G
ACHTREUNG
19.8 ppm (5t; CH2); IR (KBr): n˜ =3380 (OH), 3050–2800 cmꢀ1 (=C H,
ꢀ
de]naphthalene-10,2’-[1,3]dioxolan]-12a-ol (31): According to the general
procedure, samarium (1.13 g, 7.52 mmol), 1,2-diiodoethane (1.79 g,
6.37 mmol), HMPA (8.93 g, 49.9 mmol), 29 (0.860 g, 2.77 mmol) and
tBuOH (0.406 g, 5.48 mmol) afforded, after column chromatography on
silica gel (hexane/ethyl acetate 3.5:1 to 3:1) and preparative HPLC
(hexane/ethyl acetate 7:3), 30 (0.166 g, 19%) and 31 (0.060 g, 7%), both
as a colourless solid.
Compound 30: M.p. 123–1258C; 1H NMR (CDCl3, 500 MHz): d=7.25
(d, J=7.4 Hz, 1H; Ar), 7.20 (dt, J=7.4, 1.3 Hz, 1H; Ar), 7.14 (m, 1H;
Ar), 7.02 (dd, J=7.4, 1.0 Hz, 1H; Ar), 6.63 (d, J=9.7 Hz, 1H; CH=CH),
6.16 (dd, J=9.7, 5.9 Hz, 1H; CH=CH), 3.90–3.78 (m, 4H; OCH2), 3.27
(m, 1H; CH2), 2.48 (m, 2H; CH2, CH), 2.16 (dd, J=13.8, 5.7 Hz, 1H;
CH2), 1.99 (qd, J=13.8, 2.6 Hz, 1H; CH2), 1.77–1.68 (m, 3H; CH2, CH),
1.52 (ddd, J=13.8, 6.7, 3.4 Hz, 1H; CH2), 1.45 (dt, J=13.8, 2.6 Hz, 1H;
CH2), 1.42–1.38 (m, 1H; CH2), 1.35–1.30 (m, 2H; CH2), 1.19 ppm (td, J=
13.8, 4.1 Hz, 1H; CH2); 13C NMR (CDCl3, 126 MHz): d=137.6, 134.7
(2s; Ar), 130.3, 128.8 (2d; =CH), 127.8, 126.3, 125.9, 123.6 (4d; Ar),
+
+
ꢀ
C H); MS (EI, 80 eV): m/z (%): 240 (52) [M] , 223 (3) [MꢀH2O] , 154
(49), 129 (62), 128 (100) [C10H8]+; HRMS (80 eV): calcd for C17H20O:
240.1514; found: 240.1537. elemental analysis calcd (%) for C17H20O
(240.4): C 84.96, H 8.39; found: 84.67, H 8.25.
rac-(4aR,4bR,10bR,12aS)-1,3,4,4b,10b,11,12,12a-Octahydrobenzo[a]phen-
anthren-4a(2H)-ol (24): According to the general procedure, samarium
(0.361 g, 2.40 mmol), 1,2-diiodoethane (0.620 g, 2.20 mmol), HMPA
(3.23 g, 18.0 mmol), 21c (0.252 g, 1.00 mmol) and tBuOH (0.148 g,
2.00 mmol) afforded, after purification by column chromatography on
silica gel (hexane/ethyl acetate from 19:1 to 9:1), product 24 (0.245 g,
96%) as
a
colourless solid. M.p. 106–1088C; 1H NMR (CDCl3,
500 MHz): d=7.20–7.10 (m, 3H; Ar), 7.01 (d, J=7.5 Hz, 1H; Ar), 6.51
(d, J=9.8 Hz, 1H; =CH), 6.18 (dd, J=9.8, 5.7 Hz, 1H; =CH), 3.25 (m,
1H; CH), 2.63 (dd, J=7.0, 5.7 Hz, 1H; CH), 2.37–2.30 (m, 1H; CH2),
2.00–1.90 (m, 1H; CH2), 1.79–1.72 (m, 1H; CH), 1.68–1.54 (m, 5H; CH2,
OH), 1.46–1.20 ppm (m, 6H; CH2); 13C NMR (CDCl3, 126 MHz): d=
137.2, 134.4 (2s; Ar), 129.9, 128.4 (2d; =CH), 127.3, 126.2, 125.9, 124.1
(4d; Ar), 84.0 (s; C-4a), 47.5, 44.1, 36.5 (3d; CH), 33.2, 29.0, 26.4, 24.4,
19.8, 19.7 ppm (6t; CH2); IR (KBr): n˜ =3365 (OH), 3000–2800 cmꢀ1 (=
ꢀ ꢀ
108.6 (s, O C O), 74.0 (s; C-4a), 64.3, 63.6 (2t; OCH2), 47.7, 44.7, 37.0
(3d; CH), 35.7, 30.3, 26.4, 26.0, 25.6 ppm (5t; CH2); IR (KBr): n˜ =3460
(OH), 3030–2870 (=CH, CH), 1595 cmꢀ1 (C=C); MS (EI, 80 eV): m/z
(%): 312 (49) [M]+, 294 (25) [MꢀH2O]+, 99 (100); HRMS (80 eV): calcd
for C20H24O3: 312.17255; found: 312.17355.
ꢀ
ꢀ
C H, C H); elemental analysis calcd (%) for C18H22O (254.4): C 84.99,
H 8.72; found: C 84.90, H 8.58.
1
Compound 31: M.p. 143–1488C; H NMR (CDCl3, 500 MHz): d=7.09 (t,
rac-(4bR,6aS,11aR,11bR)-4b,5,6,6a,7,8,9,10,11,11b-Decahydro-11aH-cy-
clohepta[a]phenanthren-11a-ol (25): According to the general procedure,
samarium (0.361 g, 2.40 mmol), 1,2-diiodoethane (0.620 g, 2.20 mmol),
HMPA (3.23 g, 18.0 mmol), 21d (0.266 g, 1.00 mmol) and tBuOH
(0.148 g, 2.00 mmol) afforded, after purification by column chromatogra-
phy on silica gel (hexane/ethyl acetate 19:1 to 9:1), 25 (0.263 g, 98%) as
a colourless solid. M.p. 109–1118C; 1H NMR (CDCl3, 500 MHz): d=
7.16–7.08 (m, 3H; Ar), 7.03–6.98 (m, 1H; Ar), 6.45 (dd, J=9.9, 2.7 Hz,
1H; =CH), 6.06 (dd, J=9.9, 3.3 Hz, 1H; =CH), 3.17 (m, 1H; CH), 2.53
(m, 1H; CH), 1.97–1.15 ppm (m, 16H; CH, CH2, OH); 13C NMR
(CDCl3, 126 MHz): d=139.9, 133.1 (2s; Ar), 129.0, 127.8, 127.4, 126.2*,
125.9 (5d; Ar, =CH), 76.5 (s; C-11a), 46.5, 44.6, 37.3 (3d; CH), 33.3, 29.8,
29.5, 29.1, 24.4, 20.8, 19.7 ppm (7t; CH2), *=signal with higher intensity;
J=7.5 Hz, 1H; Ar), 6.97 (m, 2H; Ar), 6.11 (dddd, J=10.0, 4.9, 2.2,
0.7 Hz, 1H; CH2), 6.06 (dddd, J=10.0, 4.9, 3.0, 0.5 Hz, 1H; CH2), 3.86–
3.76 (m, 4H; OCH2), 3.73–3.71 (m, 1H; CH), 3.33 (m, 1H; CH2), 3.28
(m, 1H; CH2), 3.06 (ddd, J=14.9, 11.0, 7.3 Hz, 1H; CH2), 2.75 (ddd, J=
14.9, 11.0, 1.9 Hz, 1H; CH2), 1.85–1.84 (m, 1H; CH2), 1.82–1.75 (m, 3H;
CH2), 1.65 (brs, 1H; OH), 1.57–1.52 (m, 1H; CH2), 1.50–1.41 (m, 2H;
CH2, CH), 1.29 (dt, J=13.1, 3.1 Hz, 1H; CH2), 1.17 ppm (td, J=13.9,
4.5 Hz, 1H; CH2); 13C NMR (CDCl3, 126 MHz): d=139.1, 134.2, 133.8
(3s; Ar), 127.3 (d; =CH), 126.8, 126.6, 126.5 (3d; Ar), 126.3 (d; =CH),
ꢀ ꢀ
108.9 (s; O C O), 64.3, 64.2 (2t; OCH2), 48.3, 38.9 (2d; CH), 37.7, 31.4,
ꢀ
31.0, 30.5, 30.4, 25.5 ppm (6t; CH2). IR (KBr): n˜ =3540–3470 (O H),
ꢀ1
ꢀ
3030–2820 (=CH, C H), 1590 cm (C=C); elemental analysis calcd (%)
IR (KBr): n˜ =3435 (OH), 3060–2800 cmꢀ1 (=C H, C H); elemental anal-
ysis calcd (%) for C19H24O (268.4): C 85.03, H 9.01; found: C 84.90, H
8.58.
for C20H24O3 (312.4): C 76.89, H 7.74; found C 76.55, H 7.45.
ꢀ
ꢀ
rac-(4a’R,12a’R,12b’R)
(34a)
and
rac-(4a’R,12a’S,12b’R)-
1’,2’,4’,4a’,5’,6’,12’,12a’-Octahydro-12b’H-spiro[1,3-dioxolane-2,3’-tetra-
phen]-12b’-ol (34b): According to the general procedure, samarium
(1.01 g, 6.72 mmol), 1,2-diiodoethane (1.75 g, 6.20 mmol), HMPA (8.00 g,
44.6 mmol), 33 (0.771 g, 2.48 mmol) and tBuOH (0.363 g, 4.89 mmol) af-
forded 34a as a colourless solid (0.473 g, 61%) and 34b as a colourless
oil (0.087 g, 11%), after column chromatography on silica gel (hexane/
ethyl acetate 3:1). Compound 34a was further purified by repeated wash-
ing of the solid with cold Et2O. Compound 34b was purified by prepara-
tive HPLC (hexane/ethyl acetate 4:1).
Compound 34a: M.p. 151–1538C; 1H NMR (CDCl3, 500 MHz): d=7.04–
7.03 (m, 3H; Ar), 6.90 (dd, J=6.4, 1.3 Hz, 1H; Ar), 6.16 (s, 1H; =CH),
3.90–3.81 (m, 4H; OCH2), 3.20 (dd, J=17.3, 2.1 Hz, 1H; CH2), 3.10 (dd,
J=17.3, 10.4 Hz, 1H; CH2), 2.43 (d, J=10.4 Hz, 1H; CH), 2.37 (ddd, J=
12.2, 4.3, 2.2 Hz, 1H; CH2), 2.22 (dd, J=14.1, 5.9 Hz, 1H; CH2), 2.16 (dd,
J=13.1, 5.0 Hz, 1H; CH2), 2.03 (dd, J=13.1, 4.3 Hz, 1H; CH2), 1.80–1.74
rac-(4bR,6aS,11aR,12bR)-4b,6,6a,7,8,9,10,11,12,12b-Decahydrocyclooc-
ta[a]phenanthren-12(5H)-ol (26): According to the general procedure,
samarium (0.180 g, 1.20 mmol), 1,2-diiodoethane (0.310 g, 1.10 mmol),
HMPA (1.61 g, 9.00 mmol), 21e (0.140 g, 0.50 mmol) and tBuOH
(0.074 g, 1.00 mmol) afforded after purification by column chromatogra-
phy on silica gel (hexane/ethyl acetate 9:1 to 7:3) and preparative HPLC
(hexane/ethyl acetate 17:3) 26 (0.073 g, 52%, purity ꢁ90%) as a colour-
less oil. 1H NMR (CDCl3, 500 MHz): d=7.26 (brd, Jꢁ7.5 Hz, 1H; Ar),
7.16 (td, J=7.5, 1.3 Hz, 1H; Ar), 7.09, 6.99 (2tt, J=7.3, 1.3 Hz, 1H each;
Ar), 6.56 (d, J=9.8 Hz, 1H; =CH), 6.12 (dd, J=9.8, 6.0 Hz, 1H; =CH),
3.19 (m, 1H; CH), 2.56–2.50 (m, 2H; CH2), 2.38 (m, 1H; CH), 1.85–
0.86 ppm (m, 16H; CH, CH2, OH); 13C NMR (CDCl3, 126 MHz): d=
138.9, 135.4 (2s; Ar), 131.2, 129.8, 127.5, 125.9, 125.5, 122.9 (6d; Ar, =
CH), 63.1 (s; C-12), 42.8, 42.0, 35.6 (3d; CH), 32.3, 30.0, 29.6, 28.4, 26.6,
6058
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2007, 13, 6047 – 6062